The anticipated size of the Contrast-Enhanced Ultrasound Market in 2022 was USD 2,700 million and is estimated to be USD 5,243.3 million in 2023. Immediate rise in the number of performances of lung ultrasonography procedures has raised the demand for this process.
Future Market Insights has mentioned in its reports that the contrast-enhanced ultrasound market will expand at a CAGR of 5.8% between 2023 and 2033, totaling around USD 9,214.3 million by 2033.
Contrast-enhanced ultrasound (CEUS) is referred to the application of traditional medical sonography to ultrasound contrast medium. Ultrasound contrast agents rely on the different ways in which sound waves are reflected from interfaces between substances and this may be the surface of a bubble or a more complex structure.
North America is considered to be a dominant region for the Contrast-Enhanced Ultrasound Market, owing to the rising prevalence of lifestyle-associated chronic diseases and the high adoption of ultrasound modality in general diagnostics.
The factor that is expected to hinder the growth of the contrast-enhanced ultrasound market during the forecast period includes the side effects and allergic reactions associated with contrast agents.
| Attribute | Details |
|---|---|
| Projected Forecast Value (2022) | USD 2,700 million |
| Projected Forecast Value (2023) | USD 5,243.3 million |
| Projected Forecast Value (2033) | USD 9,214.3 million |
| Growth rate | 5.80% CAGR |
| Forecast period | 2023 to 2033 |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global contrast-enhanced ultrasound market grew at a CAGR of 4.7% between 2017 and 2022. Growth forecasts remain optimistic, with the market predicted to exhibit a CAGR of 5.8% between 2023 and 2033.
Major factor that is expected to propel the growth of the contrast-enhanced ultrasound market during the forecast period includes the rising incidence of cardiovascular and gastrointestinal diseases.
Introduction of Affordable Contrast Agents
Major factors that are expected to drive the growth of the contrast-enhanced ultrasound market during the forecast period include the introduction of affordable contrast agents, contrast imaging modes becoming an integral feature of ultrasound systems, and increasing ultrasound procedural volume.
Cost-Efficient, Radiation-Free, and Patient-Friendly than Other Technologies
Contrast-enhanced ultrasound (CEUS) is more cost-efficient, radiation-free, and patient-friendly than other technologies as this is another major factor that is anticipated to fuel market growth.
Immediate Increase in the Number of Lung Ultrasonography Procedures
Sudden increase in the number of lung ultrasonography procedures performed has increased the demand for this process. Rising incidence of cardiovascular and gastrointestinal diseases is expected to spur the growth of the contrast-enhanced ultrasound market during the forecast period.
Rise in the prevelance for CVDs, Liver Lesions, Kidney Lesions, Gastrointestinal Diseases, and Vascular Diseases
Increasing prevalence of CVDs, liver lesions, kidney lesions, gastrointestinal diseases, and vascular diseases globally is anticipated to boost the demand for CEUS services as these are major areas of clinical application of contrast-enhanced ultrasound systems.
Principal Consultant
Side Effects and Allergic Reactions Associated with Contrast Agents
Major factor that is expected to hamper the growth of the contrast-enhanced ultrasound market during the forecast period includes the side effects and allergic reactions associated with contrast agents, which will obstruct the market growth, and will further challenge the growth of the contrast-enhanced ultrasound market.
Rising Prevalence of Lifestyle-Associated Chronic Diseases and the High Adoption of Ultrasound Modality in General Diagnostics.
North America dominates the market and is expected to continue its stronghold for a few more years with a market share of 36.0%, attributed to the rising prevalence of lifestyle-associated chronic diseases and the high adoption of ultrasound modality in general diagnostics where the United States is expected to hold a major share in the market of 52.4%.
The North American contrast-enhanced ultrasound market is expected to expand at a 5% CAGR during the forecast period.
Rapid Growth in the Geriatric Population and Improvement of Healthcare Facilities for Treating Diseases
Future Market Insights says that Asia Pacific is anticipated to witness growth at a lucrative rate over the forecast period, owing to the rapidly growing geriatric population and improving healthcare facilities for treating diseases where Japan shares a value of 7.4%.
Blooming medical tourism in Asia Pacific economies is also expected to augment the market growth in the region. Prospering medical tourism in developing countries such as India growing at a CAGR of 6.9%,
Australia at a CAGR of 5.2%, and the Chinese market at 7.7% which further boosts the demand for world-class healthcare services. Some major market players are strategizing to increase their presence in these regions and offer products at competitive prices, which in turn is anticipated to augment the market growth.
High Demand for Technologically Advanced Medical Devices
High demand for technologically advanced medical devices in Europe is another major factor that is expected to spur the growth of the contrast-enhanced ultrasound market in the region during the forecast period with a market share of 28.0%.
United Kingdom and Germany are said to hold an important part in this region where Germany holds a market share of 7.0% and the United Kingdom is said to grow at a CAGR of 5.1%.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Targeted Type Holds a Major Portion in the Market
Targeted type holds a market share of 59.0% where molecular imaging has the potential for obtaining tissue expression profiles in a volumetric manner without invasive tissue sampling procedures and without the limitation of potential sampling errors from biopsies.
Hospitals are said to Dominate the Market Region
Hospital segment dominates the market and is projected for a revenue share of 39% where the rise in the number of emergency visits with medical conditions, like abdominal pain, thoracic trauma, and cardiac complications, has led to a rise in demand in hospitals.
Demand for Echocardiography is said to be Faring Well
Echocardiography shares a major portion of the market with a value of 60.13% where doctors use echocardiograms for helping them to diagnose heart problems, like damaged cardiac tissue, chamber enlargement, stiffening of the heart muscle, blood clots in the heart, fluid around the heart, etc.
Some of the prominent players in the global market are-
Some of the important developments of the key players in the market are:
| Attribute | Details |
|---|---|
| Growth Rate | CAGR of 5.8% from 2023 to 2033 |
| Market value in 2023 | USD 5,243.3 million |
| Market value in 2033 | USD 9,214.3 million |
| Base Year for Estimation | 2022 |
| Historical Data | 2017 to 2022 |
| Forecast Period | 2023 to 2033 |
| Quantitative Units | USD million for Value and CAGR from 2023 to 2033 |
| Report Coverage | Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
| Segments Covered | By Type, By Application, By Region |
| Regions Covered | North America; Latin America; Western Europe; Eastern Europe; South Asia and Pacific; East Asia; Middle East & Africa |
| Key Countries Profiled | United States, Canada, Brazil, Mexico, Germany, United Kingdom, France, Spain, Italy, Poland, Russia, Czech Republic, Romania, India, Bangladesh, Australia, New Zealand, China, Japan, South Korea, GCC Countries, South Africa, Israel |
| Key Companies Profiled | Trivitron Healthcare; Bracco Diagnostic Inc.; Koninklijke Philips N.V.; B.K. Medical Holding Company, Inc.; Lantheus Medical Imaging, Inc.; GE Healthcare; Daiichi Sankyo Company, Limited; Bristol-Myers Squibb Company; Acusphere, Inc.; Siemens Healthcare GmbH |
| Customization & Pricing | Available on Request |
The projected CAGR of the contrast-enhanced ultrasound market by 2033 is 5.80%.
The projected market value for 2033 is USD 9,214.3 million.
The market is estimated to secure a valuation of USD 5,243.3 million in 2023.
North America holds a significant share of the contrast-enhanced ultrasound market.
The North American market is growing due to the increasing prevalence of chronic diseases.
1. Executive Summary
2. Market Overview
3. Market Background
4. Global Market Analysis 2017 to 2022 and Forecast, 2023 to 2033
5. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Type
5.1. Non-Targeted
5.2. Targeted
6. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Application
6.1. Hepatic
6.2. Echocardiography
6.3. Cerebrovascular
6.4. Thyroid & Parathyroid
6.5. Gallbladder & Biliary Tree
6.6. Renal
6.7. Prostate
6.8. Pancreatic
6.9. Vascular
6.10. Lymphatic
6.11. Trauma
6.12. Others
7. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region
7.1. North America
7.2. Latin America
7.3. Western Europe
7.4. Eastern Europe
7.5. South Asia and Pacific
7.6. East Asia
7.7. Middle East and Africa
8. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
9. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
10. Western Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
11. Eastern Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
12. South Asia and Pacific Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
13. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
14. Middle East and Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
15. Key Countries Market Analysis
16. Market Structure Analysis
17. Competition Analysis
17.1. Trivitron Healthcare
17.2. Bracco Diagnostic Inc.
17.3. Koninklijke Philips N.V.
17.4. B.K. Medical Holding Company, Inc.
17.5. Lantheus Medical Imaging, Inc.
17.6. GE Healthcare
17.7. Daiichi Sankyo Company, Limited
17.8. Bristol-Myers Squibb Company
17.9. Acusphere, Inc.
17.10. Siemens Healthcare GmbH
18. Assumptions & Acronyms Used
19. Research Methodology
Explore Healthcare Insights
View Reports
Contrast-Enhanced Ultrasound Market
